Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $81.4100 (-2.14%) ($81.4100 - $84.9900) on Wed. Nov. 18, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.52% (three month average) | RSI | 48 | Latest Price | $81.4100(-2.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.5% a day on average for past five trading days. | Weekly Trend | LGND declines -1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(50%) IWM(49%) IWC(48%) | Factors Impacting LGND price | LGND will decline at least -1.26% in a week (0% probabilities). VIXM(-22%) UUP(-17%) VXX(-14%) UNG(-3%) EDOC(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.26% (StdDev 2.52%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $79.04(-2.91%) | Inflection Point | Yes | Resistance Level | $84.26 | 5 Day Moving Average | $83.04(-1.96%) | 10 Day Moving Average | $83.65(-2.68%) | 20 Day Moving Average | $84.26(-3.38%) | To recent high | -29.8% | To recent low | 1.3% | Market Cap | $1.308b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |